{"name":"Cellphire Therapeutics, Inc.","slug":"cellphire-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE11aVBVNXRVZW1WX3JGcGhnTUhxN3VlMUhSQUdPN3phaGJGYW02cVJVeEt3WmZpal82T1hDaVMwY3FQRXNjMm9aVm9SWXdwQWFDa1RUaTJld1VWMTdRcTlqZEhyak1TblhrS3JWeTJJc1l0RWYtZnRlRk53S3pNdw?oc=5","date":"2025-04-23","type":"trial","source":"Clinical Trials Arena","summary":"Cellphire Therapeutics halts enrolment in trial of CLPH-511 after IDMC feedback - Clinical Trials Arena","headline":"Cellphire Therapeutics halts enrolment in trial of CLPH-511 after IDMC feedback","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOdFJCS0stMGVnQ0p1WnpVYkpsd2xibTNSRC05SFlPWjExMmExWHRJYy12ckpuOWVlMGZWNzJrTHVfcFRfRUE0UXlKc3pKVnRQaWU3X0I5aVBDd3hQMEJhX3UtQjRhOXdCWWhEa3NTTHdqbzZvWWR2ZTI0bXBWVGhnTnlhb0hLRkZEdzhteHpBVXozN2xYY1g0a21oVE9GSEc5aFR5ak9PMGpLZw?oc=5","date":"2024-10-14","type":"pipeline","source":"bizjournals.com","summary":"CEO of Main Line firm steps down two months after suggesting he should be replaced - bizjournals.com","headline":"CEO of Main Line firm steps down two months after suggesting he should be replaced","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPMXRmalZDNGR3bk1xRDdkd1pvcUdpWm4wOEllRlJGMVF1eGlnd0hhTVdxN01Ud014SXNodVZLT0NtOTJRUEY3RXFtZHpFZ1Ryd2U3MDRsbXRZTk9RNDdvOGxoblNxdlRnSy00Z0o5SUo3S2tTM3pfWGYtdEdtMXNoYzVfa3VsSUk0VE44WXY2aGNGTXdVd0prWjJMZ05KWGFGc0V2OHU5Qjhycy1IWURKb3lWbw?oc=5","date":"2022-07-15","type":"regulatory","source":"Fierce Biotech","summary":"Chutes & Ladders—Agios makes CEO change less than 6 months after latest FDA approval - Fierce Biotech","headline":"Chutes & Ladders—Agios makes CEO change less than 6 months after latest FDA approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNQ3JYNFlvOFhUZHRqNWQ3c2YtWjZJTlBFcDRlalozVmpNLWhlbGI1QzhISnZUbjU1MlY2NUY4SnYyUEE5a2FERGdlSjFyVDQyWEtWRllSc1VzQkxUVmdsbTh0UW54UjdxT29HYnhIUjhpdTRIWXBjeDFscmpmRFFiX2k1S1p5UFpLMHlQSVNhYzZfdEpnMDBlMUVtcWtmZw?oc=5","date":"2022-07-13","type":"pipeline","source":"Contract Pharma","summary":"NRx Pharmaceuticals Appoints Stephen Willard as CEO - Contract Pharma","headline":"NRx Pharmaceuticals Appoints Stephen Willard as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOZERDMUFyNlFGOGhVbk5NOHM0Ty1yYlN5ZmgxeVR4Q1hEamVvUUFkZDhad05VYWRhcGx6dUo1VHBGZ2V2VXRMSUhtcUZDUW5mZnQyNWRDUnEtaTZ1V2ZPb011OG5aTEpFV2FUNW50UTZUS2R0ZFNzVnBXMHUwdDdxcjFrQTFqNFlOR0VtcTVUS3U?oc=5","date":"2022-07-13","type":"pipeline","source":"citybiz","summary":"NRx Pharmaceuticals Appoints Stephen Willard CEO - citybiz","headline":"NRx Pharmaceuticals Appoints Stephen Willard CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxNZ2VBR0FSWjBMUHhrSzVGRHdaRHd4OGtZalBQbDRrU3YxOERUVzlMYnMwQ0lHUTMtT0xDRFFab2o0LWlvNXh2cjM0RFNDYXJ6UHlkRDFLYXY5MWZlSFhjVWhBem1RcG0ySjExMkFlSzR4bGRjT3JjZUZSQmRRTkxhdlV4Vl9DSXBzb0UyLVo2eVVIS3BUV3VZMy1rUjdSQlRfV21fVS13VzN5NHhBQnBsYk1ERDhxcXY3X3NZMS1hN2NsNkVISENVZlEya2lBQTR4RFdDU0ZEbkQ4M3RleTFFZ2RMSG5ESHpYSW01YmdR?oc=5","date":"2022-07-13","type":"pipeline","source":"PR Newswire","summary":"NRx Pharmaceuticals Announces the Appointment of Stephen Willard, Chief Executive Officer and Director - PR Newswire","headline":"NRx Pharmaceuticals Announces the Appointment of Stephen Willard, Chief Executive Officer and Director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNWGxRcWRwRFBYQ2hOZzV5a3dCc1VQRWdBTHMwWng5X1UtQV9YUldHanAwdGIyZGs1ay1MU2xPd0FqLV9IU1BuTVo3SExxQlZTdy1FZDBna05yb210M3lhcnJnM2RTTUVsV1hwY2R6ZGFMWHI4OGRtUDRrVHhwd29Nbi01UGNwcThOT0ZuclBLOU9GeThrUjhndURQX1hqTVdweEE?oc=5","date":"2022-07-13","type":"pipeline","source":"bizjournals.com","summary":"NRx Pharmaceuticals names new CEO - bizjournals.com","headline":"NRx Pharmaceuticals names new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQUG9jbVhyaWNCajRwMkRXUlZfRWNkdWxJYmlOVVRVTF9JLVZuN2xUMUVubHF5OXpnRFlmWHVBb3ZSMW9QalZaVVZvbXlOOEk2OE9qVWNaemlCeGNSd0dRX0Q1MXI4bnlMeGZmdS01ZW5hTkFkMTd5TW9hQVp3b2k4akJRbURicEEzeHduNmF6WERwS2dN?oc=5","date":"2021-04-20","type":"pipeline","source":"BioSpace","summary":"Cellphire Therapeutics Names Michael Gaffney as Company’s New CEO - BioSpace","headline":"Cellphire Therapeutics Names Michael Gaffney as Company’s New CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQldXTlBITUptRWZWZWtsWjRxX01KbEFBMXhjS3ZXTDFRc3VRREFOMGljbHdQVkJGRDM2QmtHR3E1Q2RrM2djT3p6NHpSbGlKbTd5LUxOZXZDLVJGd3hhTDU5R1l0elJmVjRBR1NtSkowUUI2cElmVm4zajdqa2VSZFZ1SzJRdnpDVHJWWFRDOUhpYWtMSkZpaG02MnpSSmEzSXgwZTNtME9aTkgxczBjbFBkdGZpTi1VbExwYXB6U0xPQlg3WlZ0WTl6eTdycXhDNjl3VHlOX1gwWGtOZE5HS0dR?oc=5","date":"2021-04-02","type":"pipeline","source":"PR Newswire","summary":"Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management - PR Newswire","headline":"Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}